<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04157660</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-NR. 2012-0251_3</org_study_id>
    <nct_id>NCT04157660</nct_id>
  </id_info>
  <brief_title>Effect of Short-term Oxygen During CPET in HFpEF</brief_title>
  <official_title>Effect of Short-term Ambulatory Oxygen Therapy on Cardiopulmonary Exercise Capacity (CPET) in Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a randomized, sham-controlled crossover trial the investigators will test whether
      supplemental oxygen given during cardiopulmonary exercise testing will improve exercise
      performance and physiological parameters in patients with heart failure with preserved
      ejection fraction.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 12, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Work Rate (Watt)</measure>
    <time_frame>1 day</time_frame>
    <description>Maximal Work Rate (Watt max) measured during cardiopulmonary exercise test oxygen vs. room air</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endurance Time (s)</measure>
    <time_frame>1 day</time_frame>
    <description>Endurance (s) with 75% Wmax measured during cardiopulmonary exercise test oxygen vs. room air</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak Oxygen uptake (VO2 max)</measure>
    <time_frame>1 day</time_frame>
    <description>measured during cardiopulmonary exercise test oxygen vs. room air</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Exchange Ratio (RER)</measure>
    <time_frame>1 day</time_frame>
    <description>measured during cardiopulmonary exercise test oxygen vs. room air</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood parameters (pH)</measure>
    <time_frame>1 day</time_frame>
    <description>measured during cardiopulmonary exercise test oxygen vs. room air</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood parameters (PaO2)</measure>
    <time_frame>1 day</time_frame>
    <description>measured during cardiopulmonary exercise test oxygen vs. room air</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood parameters (PaCO2)</measure>
    <time_frame>1 day</time_frame>
    <description>measured during cardiopulmonary exercise test oxygen vs. room air</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood parameters (Lactat)</measure>
    <time_frame>1 day</time_frame>
    <description>measured during cardiopulmonary exercise test oxygen vs. room air</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood parameters (Bicarbonate)</measure>
    <time_frame>1 day</time_frame>
    <description>measured during cardiopulmonary exercise test oxygen vs. room air</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle tissue oxygen</measure>
    <time_frame>1 day</time_frame>
    <description>Oxygen Saturation in the muscle measured with near-infrared spectroscopy oxygen vs. room air</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cerebral tissue oxygen</measure>
    <time_frame>1 day</time_frame>
    <description>Oxygen Saturation in the brain measured with near-infrared spectroscopy oxygen vs. room air</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">14</enrollment>
  <condition>Heart Failure, Diastolic (HFpEF)</condition>
  <arm_group>
    <arm_group_label>Supplemental oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supplemental oxygen will be applied via a mask during CPET</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham room air</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Room air will be applied similarly to oxygen</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oxygen application</intervention_name>
    <description>Oxygen application Supplemental oxygen via mask</description>
    <arm_group_label>Supplemental oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham room air</intervention_name>
    <description>Room air will be applied via mask</description>
    <arm_group_label>Sham room air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HFpEF, stable medication for at least 4 weeks.

        Exclusion Criteria:

          -  instable status, pregnancy, clinically relevant concomitant diseases, inability to
             follow the study procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvia Ulrich Somaini, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of Pneumology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silvia Ulrich Somaini, Prof. Dr.</last_name>
    <phone>0041442552220</phone>
    <email>silvia.ulrich@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Zurich, Division of Pneumology</name>
      <address>
        <city>ZÃ¼rich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Ulrich Somaini, Prof. Dr.</last_name>
      <phone>0041442552220</phone>
      <phone_ext>0041442552220</phone_ext>
      <email>silvia.ulrich@usz.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>August 30, 2019</study_first_submitted>
  <study_first_submitted_qc>November 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2019</study_first_posted>
  <last_update_submitted>November 7, 2019</last_update_submitted>
  <last_update_submitted_qc>November 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Diastolic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

